LOGIN
Oral Corticosteroid Improves Walking Ability in Patients with Refractory Lumbar Spinal Stenosis
January 2021
Oral Corticosteroid Improves Walking Ability in Patients with Refractory Lumbar Spinal Stenosis
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
A short-term oral corticosteroid for refractory lumbar spinal stenosis: a double-blinded randomized placebo-controlled clinical trial
Int J Rehabil Res. 2020 Dec;43(4):342-346.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Ninety-three patients with refractory lumbar spinal stenosis (LSS) were randomized to receive 1 week of oral corticosteroid (prednisolone; n=47) or a placebo (n=46) for the improvement of functionality and relief of pain. The primary outcomes of interest was the improvement in walking distance and Oswestry Disability Index (ODI). The secondary outcomes of interest was pain score on a Numeric Ratin...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.